Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation
Clinical trial NCT05145283 · COMPLETED
Trial details
- NCT number
- NCT05145283
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-16
- Primary completion
- 2026-01-05
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.